Determinar niveles de antígeno prostático específico en pacientes con prostatitis como alerta de adenocarcinoma, estudio a realizar con pacientes de los laboratorios de Interlab durante el período de febrero a julio del 2013
Cargando...
Fecha
2014
Autores
Título de la revista
ISSN de la revista
Título del volumen
Editor
Universidad de Guayaquil. Facultad de Ciencias Médicas. Carrera de Tecnología Médica
Resumen
Este trabajo de investigación descriptivo, bibliográfico y prospectivo se realizó con el propósito de que las personas conozcan de cómo se lleva a cabo la prueba de antígeno prostático específico sus ventajas y desventajas para saber que detecta la prueba y la seguridad y confiabilidad que este método brinda. Y se tomaron en cuenta las diferentes fuentes de información de libros, entrevistas y lo más importante la ayuda que el profesional aportó en la investigación fueron de gran apoyo. PSA se hace para ayudar a diagnosticar y hacerle seguimiento al cáncer de próstata en hombres. Es una proteína producida por células de la próstata. PSA representa al antígeno prostático específico. El examen se puede hacer para detectar cáncer de próstata. También se utiliza para vigilar a pacientes después del tratamiento para cáncer de próstata para ver si el cáncer ha reaparecido. Un nivel de PSA alto ha sido asociado con un incremento en la probabilidad de tener cáncer de próstata. En general, los siguientes resultados indican una necesidad de control y pruebas posteriores: Un PSA de 4 nanogramos por mililitro (ng/mL) para la mayoría de los hombres. Para los hombres menores de 49 años, niveles por encima de 2.5 ng/mL. Para los hombres de 50 a 59 años, niveles por encima de 3.5 ng/mL. Para los hombres de 60 a 69 años, niveles por encima de 4.5 ng/mL. Una elevación significativa de un año al siguiente también puede indicar un riesgo más alto de tener cáncer de próstata. Los afroamericanos y asiáticos americanos pueden necesitar pruebas de control si tienen niveles de PSA más bajos. Un PSA que cambia rápidamente, incluso dentro del rango normal, aumenta la probabilidad de cáncer. Esta tesis es muy importante para la por que explica la enfermedad, el procedimiento de la técnica de antígeno prostático específico en pacientes con prostatitis, su prevención y su tratamiento para que no concluya en un adenocarcinoma. Por ello, el uso de análisis altamente sensibles es una aproximación altamente utilizada en el diagnóstico de la infección con prostatitis.
This descriptive, bibliographical and prospective research work was carried out with the purpose of letting people know how the prostate-specific antigen test is carried out, its advantages and disadvantages to know that it detects the test and the safety and reliability that this method provides. . And they took into account the different sources of information from books, interviews and most importantly the help that the professional contributed in the research were of great support. PSA is done to help diagnose and monitor prostate cancer in men. It is a protein produced by prostate cells. PSA represents the prostate-specific antigen. The test can be done to detect prostate cancer. It is also used to monitor patients after treatment for prostate cancer to see if the cancer has reappeared. A high PSA level has been associated with an increased likelihood of having prostate cancer. In general, the following results indicate a need for control and subsequent testing: A PSA of 4 nanograms per milliliter (ng / mL) for most men. For men under 49, levels above 2.5 ng / mL. For men aged 50 to 59 years, levels above 3.5 ng / mL. For men from 60 to 69 years old, levels above 4.5 ng / mL. A significant elevation from one year to the next may also indicate a higher risk of having prostate cancer. African Americans and Asian Americans may need control tests if they have lower PSA levels. A PSA that changes rapidly, even within the normal range, increases the likelihood of cancer. This thesis is very important for why it explains the disease, the procedure of the prostate-specific antigen technique in patients with prostatitis, its prevention and its treatment so that it does not end in an adenocarcinoma. Therefore, the use of highly sensitive analyzes is a highly used approach in the diagnosis of infection with prostatitis.
This descriptive, bibliographical and prospective research work was carried out with the purpose of letting people know how the prostate-specific antigen test is carried out, its advantages and disadvantages to know that it detects the test and the safety and reliability that this method provides. . And they took into account the different sources of information from books, interviews and most importantly the help that the professional contributed in the research were of great support. PSA is done to help diagnose and monitor prostate cancer in men. It is a protein produced by prostate cells. PSA represents the prostate-specific antigen. The test can be done to detect prostate cancer. It is also used to monitor patients after treatment for prostate cancer to see if the cancer has reappeared. A high PSA level has been associated with an increased likelihood of having prostate cancer. In general, the following results indicate a need for control and subsequent testing: A PSA of 4 nanograms per milliliter (ng / mL) for most men. For men under 49, levels above 2.5 ng / mL. For men aged 50 to 59 years, levels above 3.5 ng / mL. For men from 60 to 69 years old, levels above 4.5 ng / mL. A significant elevation from one year to the next may also indicate a higher risk of having prostate cancer. African Americans and Asian Americans may need control tests if they have lower PSA levels. A PSA that changes rapidly, even within the normal range, increases the likelihood of cancer. This thesis is very important for why it explains the disease, the procedure of the prostate-specific antigen technique in patients with prostatitis, its prevention and its treatment so that it does not end in an adenocarcinoma. Therefore, the use of highly sensitive analyzes is a highly used approach in the diagnosis of infection with prostatitis.
Descripción
PDF
Palabras clave
Adenocarcinoma, Prostatitis, Laboratorio Interlab, Cantón Guayaquil, Ecuador, Antígeno prostático específico